Therapy of hypertension in African Americans

American Journal of Cardiovascular Drugs

Volumn 11, Issue 2, 2011, Pages 83-92

  Flack, John M ^a   Nasser, Samar A ^a   Levy, Phillip D ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

ACE inhibitors, therapeutic use; Aldosterone receptor antagonists, therapeutic use; Amiloride, therapeutic use; Amlodipine, therapeutic use; Angiotensin receptor antagonists, therapeutic use; Benazepril, therapeutic use; Beta adrenergic receptor antagonists, therapeutic use; Calcium channel antagonists, therapeutic use; Chlortalidone, therapeutic use; Clonidine, therapeutic use; Diltiazem, therapeutic use; Eplerenone, therapeutic use; Ethnic groups; Hydrochlorothiazide, therapeutic use; Hypertension, treatment; Loop diuretics, therapeutic use; Metolazone, therapeutic use; Renin angiotensin system; Spironolactone, therapeutic use; Thiazide diuretics, therapeutic use; Verapamil, therapeutic use

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; THIAZIDE DIURETIC AGENT;

AFRICAN AMERICAN; ALBUMINURIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; DIABETES MELLITUS; DIURETIC THERAPY; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STRATIFICATION; WEIGHT REDUCTION;

AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 79953237669     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/11586930-000000000-00000     Document Type: Article

References (46)

1. Brewster LM, van Montfrans V, Kleijnen J. Systematic review: Antihypertensive drug therapy in black patients. Ann Intern Med 2004; 141: 614-27 (Pubitemid 39390539)
2. Flack JM, Oparil S, Pratt JH, et al. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol 2003; 41 (7): 1148-55 (Pubitemid 36384902)
3. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52: 818-27
4. Giles T, Aranda Jr JM, Suh D-C, et al. Ethnic/racial variations in blood pressure awareness, treatment, and control. J Clin Hypertens (Greenwich) 2007; 9: 345-54
5. Centers for Disease Control. Compressed mortality file: underlying causeof- death, 2008. National Center for Health Statistics [online]. Available from URL: Http://wonder.cdc.gov/mortSQL.html [Accessed 2009 Sep 22]
6. Wong MD, Shapiro MF, Boscardin WJ, et al. Contribution of major diseases to disparities in mortality. N Engl J Med 2002; 347 (20): 1585-92 (Pubitemid 35315840)
7. Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998 Jan; 22 (1): 39-47 (Pubitemid 28036587)
8. Rocchini AP, Mao HZ, Babu K, et al. Clonidine prevents insulin resistance and hypertension in obese dogs. Hypertension 1999 Jan; 33 (1 Pt 2): 548-53 (Pubitemid 29065718)
9. Rocchini AP. Obesity hypertension, salt sensitivity and insulin resistance. Nutr Metab Cardiovasc Dis 2000 Oct; 10 (5): 287-94
10. Hall JE, Henegar JR, Dwyer TM, et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 2004; 11: 41-54 (Pubitemid 38174673)
11. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002; 4: 393-404 (Pubitemid 35469393)
12. Taler SJ. Treatment of resistant hypertension. Curr Hypertens Rep 2005 Oct; 7 (5): 323-9 (Pubitemid 41541744)
13. Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for endstage renal disease. Ann Intern Med 2006 Jan 3; 144 (1): 21-8 (Pubitemid 46780716)
14. Flack JM, Grimm Jr RH, Staffileno B, et al. New salt-sensitivity metrics: Variability-adjusted blood pressure change and urinary sodium to creatinine ratio. Ethn Dis 2002 Winter; 12 (1): 10-9 (Pubitemid 34477390)
15. Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl JMed 1989 Aug 31; 321 (9): 580-5 (Pubitemid 19212870)
16. Morris Jr RC, Sebastian A, Forman A, et al. Normotensive salt sensitivity: Effects of race and dietary potassium. Hypertension 1999 Jan; 33 (1): 18-23 (Pubitemid 29061836)
17. Boddi M, Poggesi L, CoppoM, et al. Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. Hypertension 1998; 31 (3): 836-42 (Pubitemid 28108584)
18. Price DA, Fisher ND, Osei SY, et al. Renal perfusion and function in healthy African Americans. Kidney Int 2001; 59 (3): 1037-43 (Pubitemid 32206866)
19. SteinCM, LangCC,NelsonR, et al.Vasodilation in blackAmericans: Attenuated nitric oxide-mediated responses. Clin Pharmacol Ther 1997; 62 (4): 436-43 (Pubitemid 27475228)
20. Houghton JL, Philbin EF, Strogatz DS, et al. The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine. J Am Coll Cardiol 2002; 39: 1314-22 (Pubitemid 34297871)
21. Malinski T. Understanding nitric oxide physiology in the heart: A nanomedical approach. Am J Cardiol 2005; 96 Suppl.: 13i-24i (Pubitemid 41437920)
22. Nasser SA, Lai Z, O'Connor S, et al. Does earlier attainment of blood pressure goal translate into fewer cardiovascular events? Curr Hypertens Rep 2008 Oct; 10 (5): 398-404
23. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: An update of the International Society on Hypertension in Blacks consensus statement. International Society on Hypertension in Blacks. Hypertension 2010 Nov; 56 (5): 780-800
24. Sacks FM, Svetkey LP, Vollmer WM, et al., DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344 (1): 3-10 (Pubitemid 32064838)
25. Liebson PR, Grandits GA, Dianzumba S, et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91 (3): 698-706
26. Chobanian AV, Bakris GL, Black HR, et al., and the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-52 (Pubitemid 37553153)
27. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension inmen: A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328 (13): 914-21 (Pubitemid 23086643)
28. Wright Jr JT, Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005; 293: 1595-608 (Pubitemid 40471790)
29. Mokwe E, Ohmit SE, Nasser SA, et al. Determinants of blood pressure response to quinapril in black and white hypertensive patients: The Quinapril Titration Interval Management Evaluation trial. Hypertension 2004; 43: 1202-7 (Pubitemid 38691741)
30. Sehgal AR. Overlap between whites and blacks in response to antihypertensive drugs. Hypertension 2004; 43: 566-72 (Pubitemid 38282429)
31. Menon DV, Arbique D, Wang Z, et al. Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients. J Clin Endocrinol Metab 2009; 94 (4): 1361-6
32. Feldman RD, Zou GY, Vandervoort MK, et al. A simplified approach to the treatment of uncomplicated hypertension: A cluster randomized, controlled trial. Hypertension 2009 Apr; 53 (4): 646-53
33. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-28
34. Van den Meiracker A, Man in't Veld AJ, van Eck HR, et al. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: Studies with pindolol in hypertension. J Hypertens Suppl. 1984; 2 (3): S581-3
35. Levenson J, Gariepy J, Megnien JL, et al. Diuretics and arteriolar resistance and arterial compliance in human hypertension. Eur Heart J 1992; 13 Suppl. G: 48-52 (Pubitemid 23077955)
36. Lund-Johansen P. Hemodynamic changes in long-term diuretic therapy of essential hypertension: A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide. Acta Med Scand 1970; 187 (6): 509-18
37. Ernst ME, Carter BL, GoerdtCJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006 Mar; 47 (3): 352-8 (Pubitemid 43740274)
38. Ernst ME, Carter BL, Zheng S, et al. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: Effects on systolic blood pressure and potassium. Am J Hypertens 2010; 23 (4): 440-6
39. Schmidlin O, Forman A, TanakaM, et al. NaCl-induced renal vasoconstriction in salt-sensitive African Americans: Antipressor and hemodynamic effects of potassium bicarbonate. Hypertension 1999; 33 (2): 633-9 (Pubitemid 29091639)
40. Morris RC Jr, Sebastian A, Forman A, et al. Normotensive salt sensitivity: Effects of race and dietary potassium. Hypertension 1999 Jan; 33 (1): 18-23 (Pubitemid 29061836)
41. Wilson DK, Sica DA, Miller SB. Effects of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents. Hypertension 1999; 34 (2): 181-6 (Pubitemid 29409212)
42. Zhou MS, Kosaka H, Yoneyama H. Potassium augments vascular relaxation mediated by nitric oxide in the carotid arteries of hypertensive Dahl rats.AmJ Hypertens 2000; 13 (6 Pt 1): 666-72
43. Tolvanen JP, Mäkynen H, Wu X, et al. Effects of calcium and potassium supplements on arterial tone in vitro in spontaneously hypertensive rats. Br J Pharmacol 1998; 124 (1): 119-28 (Pubitemid 28210051)
44. Brown NJ, Ray WA, Snowden M, et al. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996 Jul; 60 (1): 8-13 (Pubitemid 26279215)
45. Nishizaka MK, Zaman MA, CalhounDA. Efficacy of low-dose spironolactone in subjects with resistant hypertension.AmJHypertens 2003 Nov; 16 (11 Pt 1): 925-30 (Pubitemid 37315491)
46. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis. JAMA 2001; 285: 2719-28 (Pubitemid 32525368)